OWL > Management team > Pablo Ortiz, MD, PhD

Management team

Pablo Ortiz, MD, PhD

Chief Scientific Officer

Pablo Ortiz became MD by Universidad Autónoma of Madrid (1972-1978) where also made his PhD (1984-1990, Cum Laude) and Postgraduate with Honors in the Autonomous of Barcelona University about “Biostatistics in Medicine” (1980-1981).

He counts with an extensive training in management R&D projects, and clinical trials, and over 25 years of experience (1979-2004) within Medical Department of Boehringer Ingelheim.

He was named Honorary Professor in the Faculty of Medicine of Málaga University since 2000 and from 2008 to 2011, and teaches at the Master in Biotechnology organized by University Pompeu Fabra of Barcelona. He has published 30 papers in international journals.

Since June 2004 he was CEO at Digna Biotech, a company created as a spin-off of University of Navarra and left in Nov 2012 with 4 clinical-Stage Products (1 small peptide, 2 proteins and 1 viral vector).

He is member of the Board of Trustees Fundación Moderna (Goverment of Navarra) and for 2 Biotechs companies (Bionure and ProRetina). He is head of Biotechs division at Pivotal (Clinical CRO) from January 2013 to date. He joined OWL in January 2013 as a senior consultant and in June 2014 as Chief Executive Officer and since June 2020 holds position of Chief Scientific Officer. 

Back to management team
OWL is a trading name of
Parque Tecnológico de Bizkaia
Edificio 502 - Planta 0
48160 Derio - Bizkaia - Spain
+34 94 431 85 40

With this web OWL intends to provide users with information to better understand their health and their diagnosed illnesses. You should consult with a
qualified physician for diagnosis and for answers to your personal questions/circunstances.
Last update: 07/20/2022

With the collaboration of: